Sungen Bioscience Co., LTD.

Sungen Bioscience Co., Ltd. (SungenBio) is an innovation-driven biotechnology firm specializing in the research, development, and industrial-scale fermentation of bioactive ingredients, including nattokinase, Vitamin K2 (MK-7), and gamma-polyglutamic acid (γ-PGA). Operating from its specialized biotechnology park in China, the company utilizes advanced fermentation and multi-stage membrane separation technologies to produce high-purity, standardized substances for the food, pharmaceutical, and nutritional supplement industries. Its proprietary production processes, often patent-protected, prioritize natural fermentation without the use of chemical solvents or preservatives, resulting in high-activity, clean-label ingredients marketed under brands such as ESSEK2 and EsseZyme.

The company serves as a critical supplier and solution provider for global partners seeking high-quality cardiovascular health and bone-support ingredients. By integrating independent R&D with academic cooperation, SungenBio maintains rigorous GMP-standard quality management, supporting its efforts to meet international safety and regulatory standards, including European Novel Food approvals. Beyond ingredient manufacturing, the firm invests in clinical research to validate the efficacy of its products, addressing health use cases such as cardiovascular function, osteoporosis prevention, and blood sugar management. This commitment to scientific backing and scalable, eco-friendly manufacturing positions SungenBio as an established player in the global bioactive ingredient market.